953 related articles for article (PubMed ID: 20331929)
1. Treatment of cannabis use among people with psychotic or depressive disorders: a systematic review.
Baker AL; Hides L; Lubman DI
J Clin Psychiatry; 2010 Mar; 71(3):247-54. PubMed ID: 20331929
[TBL] [Abstract][Full Text] [Related]
2. Psychological and psychosocial interventions for cannabis cessation in adults: a systematic review short report.
Cooper K; Chatters R; Kaltenthaler E; Wong R
Health Technol Assess; 2015 Jul; 19(56):1-130. PubMed ID: 26202542
[TBL] [Abstract][Full Text] [Related]
3. Psychosocial and pharmacological treatments for cannabis use disorder and mental health comorbidities: a narrative review.
Lees R; Hines LA; D'Souza DC; Stothart G; Di Forti M; Hoch E; Freeman TP
Psychol Med; 2021 Feb; 51(3):353-364. PubMed ID: 33536109
[TBL] [Abstract][Full Text] [Related]
4. Psychological interventions for alcohol misuse among people with co-occurring depression or anxiety disorders: a systematic review.
Baker AL; Thornton LK; Hiles S; Hides L; Lubman DI
J Affect Disord; 2012 Aug; 139(3):217-29. PubMed ID: 21890213
[TBL] [Abstract][Full Text] [Related]
5. [Motivational interviewing for cannabis users with psychotic disorders].
Bonsack C; Montagrin Y; Favrod J; Gibellini S; Conus P
Encephale; 2007 Oct; 33(5):819-26. PubMed ID: 18357854
[TBL] [Abstract][Full Text] [Related]
6. Treatment of cannabis use among people with psychotic disorders: a critical review of randomised controlled trials.
Baker AL; Thornton LK; Hides L; Dunlop A
Curr Pharm Des; 2012; 18(32):4923-37. PubMed ID: 22716135
[TBL] [Abstract][Full Text] [Related]
7. A systematic review of technology-based psychotherapeutic interventions for decreasing cannabis use in patients with psychosis.
Tatar O; Bastien G; Abdel-Baki A; Huỳnh C; Jutras-Aswad D
Psychiatry Res; 2020 Jun; 288():112940. PubMed ID: 32344316
[TBL] [Abstract][Full Text] [Related]
8. A phase-specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial.
Barrowclough C; Marshall M; Gregg L; Fitzsimmons M; Tomenson B; Warburton J; Lobban F
Psychol Med; 2014 Oct; 44(13):2749-61. PubMed ID: 25065535
[TBL] [Abstract][Full Text] [Related]
9. Intervention efficacy in trials targeting cannabis use disorders in patients with comorbid psychosis systematic review and meta-analysis.
Hjorthoj CR; Baker A; Fohlmann A; Nordentoft M
Curr Pharm Des; 2014; 20(13):2205-11. PubMed ID: 23829367
[TBL] [Abstract][Full Text] [Related]
10. [Related, induced and associated psychiatric disorders to cannabis].
Laqueille X
Rev Prat; 2005 Jan; 55(1):30-4. PubMed ID: 15801394
[TBL] [Abstract][Full Text] [Related]
11. Computer-based psychological treatment for comorbid depression and problematic alcohol and/or cannabis use: a randomized controlled trial of clinical efficacy.
Kay-Lambkin FJ; Baker AL; Lewin TJ; Carr VJ
Addiction; 2009 Mar; 104(3):378-88. PubMed ID: 19207345
[TBL] [Abstract][Full Text] [Related]
12. State of the art treatments for cannabis dependence.
Danovitch I; Gorelick DA
Psychiatr Clin North Am; 2012 Jun; 35(2):309-26. PubMed ID: 22640758
[TBL] [Abstract][Full Text] [Related]
13. Comorbid Cannabis and Tobacco Use Disorders in Hospitalized Patients with Psychotic-Spectrum Disorders.
Reeves LE; Gaudiano BA; Metrik J; Guzman Holst C; Morena A; Sydnor VJ; Weinstock LM; Epstein-Lubow G
J Dual Diagn; 2018; 14(3):171-180. PubMed ID: 30265850
[TBL] [Abstract][Full Text] [Related]
14. Age-varying effects of cannabis use frequency and disorder on symptoms of psychosis, depression and anxiety in adolescents and adults.
Leadbeater BJ; Ames ME; Linden-Carmichael AN
Addiction; 2019 Feb; 114(2):278-293. PubMed ID: 30276906
[TBL] [Abstract][Full Text] [Related]
15. Sequential treatment of mood and anxiety disorders.
Fava GA; Ruini C; Rafanelli C
J Clin Psychiatry; 2005 Nov; 66(11):1392-400. PubMed ID: 16420076
[TBL] [Abstract][Full Text] [Related]
16. The clinical effectiveness of concise cognitive behavioral therapy with or without pharmacotherapy for depressive and anxiety disorders; a pragmatic randomized controlled equivalence trial in clinical practice.
Meuldijk D; Carlier IV; van Vliet IM; van Veen T; Wolterbeek R; van Hemert AM; Zitman FG
Contemp Clin Trials; 2016 Mar; 47():131-8. PubMed ID: 26762883
[TBL] [Abstract][Full Text] [Related]
17. Psychological therapies for the treatment of post-traumatic stress disorder in children and adolescents (Review).
Gillies D; Taylor F; Gray C; O'Brien L; D'Abrew N
Evid Based Child Health; 2013 May; 8(3):1004-116. PubMed ID: 23877914
[TBL] [Abstract][Full Text] [Related]
18. Risks associated with the non-medicinal use of cannabis.
Hoch E; Bonnet U; Thomasius R; Ganzer F; Havemann-Reinecke U; Preuss UW
Dtsch Arztebl Int; 2015 Apr; 112(16):271-8. PubMed ID: 25939318
[TBL] [Abstract][Full Text] [Related]
19. Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis.
Edwards J; Elkins K; Hinton M; Harrigan SM; Donovan K; Athanasopoulos O; McGorry PD
Acta Psychiatr Scand; 2006 Aug; 114(2):109-17. PubMed ID: 16836598
[TBL] [Abstract][Full Text] [Related]
20. Reasons for cannabis use in psychosis.
Schofield D; Tennant C; Nash L; Degenhardt L; Cornish A; Hobbs C; Brennan G
Aust N Z J Psychiatry; 2006; 40(6-7):570-4. PubMed ID: 16756582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
